List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 141 studies with search of: Uveitis
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: Sirolimus (rapamycin)
2 Recruiting Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)
Condition: Uveitis
Intervention: Drug: Adalimumab
3 Active, not recruiting Multicenter Uveitis Steroid Treatment (MUST) Trial
Condition: Uveitis
Interventions: Drug: fluocinolone acetonide intraocular implant;   Drug: oral corticosteroid with immunosuppressive agents as needed
4 Recruiting Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis
Conditions: Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: AEB071
5 Terminated Study to Treat Uveitis Associated Macular Edema
Conditions: Cystoid Macular Edema;   Uveitis
Intervention: Drug: denufosol tetrasodium (INS37217) Intravitreal Injection
6 Recruiting Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 type 1;   Drug: AIN457 type 2
7 Recruiting Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
Conditions: Uveitis, Intermediate;   Macular Edema;   Multiple Sclerosis
Interventions: Drug: Interferon beta;   Drug: Methotrexate
8 Completed Efalizumab to Treat Uveitis
Conditions: Uveitis;   Intraocular Inflammatory Diseases
Intervention: Drug: Raptiva (efalizumab)
9 Completed A Study of LX211 in Clinically Quiescent Non-Infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
Intervention: Drug: LX211
10 Completed A Study of LX211 in Active Sight Threatening, Non-Infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
Intervention: Drug: LX211
11 Recruiting Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis
Condition: Anterior Uveitis
Intervention: Biological: ESBA105
12 Recruiting Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti
Condition: Anterior Uveitis
Intervention: Drug: Sirolimus
13 Completed Combination Daclizumab/Denileukin Diftitox to Treat Uveitis
Condition: Non-Infectious Intermediate and Posterior Uveitis
Intervention: Drug: Daclizumab
14 Terminated The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
Condition: Non-Infectious Uveitis
Interventions: Drug: Basiliximab;   Drug: Placebo
15 Completed Human Anti-Tac (Daclizumab) to Treat JIA-associated Uveitis
Conditions: Anterior Uveitis;   Arthritis, Juvenile Idiopathic;   Daclizumab;   Iritis;   Immunosuppression
Intervention: Drug: HAT, Daclizumab
16 Completed Phase 2 Study of MM-093 to Treat Patients With Uveitis
Condition: Uveitis
Interventions: Drug: MM-093;   Other: Placebo
17 Completed Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis
Condition: Uveitis
Intervention: Drug: Daclizumab
18 Not yet recruiting Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
Condition: Non-infectious Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
19 Completed Effect of Pregnancy on Uveitis
Conditions: Postpartum Period;   Pregnancy;   Uveitis
Intervention:
20 Active, not recruiting Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
Condition: Uveitis
Intervention: Drug: everolimus

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services